TrialMicrobial drug resistance (Larchmont, N.Y.)2022

Mechanisms of Reduced Susceptibility to Cefiderocol Among Isolates from the CREDIBLE-CR and APEKS-NP Clinical Trials.

Patrice Nordmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.